닥플 플러스
2026년 대한위암학회 국제학술대회 (KINGCA WEEK 2026) (1일차)
대한위암학회
연수평점 :5점
오프라인
주관
대한위암학회
교육일자
2026-09-17
수강료
500,000원
교육형태
오프라인
등록일시
2026-07-21
교육시간
24시간 44분
연수평점
5점
장소
서울특별시 롯데호텔 서울 2층
교육종류
내과, 외과, 영상의학과, 방사선종양학과, 병리과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-09-17 | 08:50~09:00 | Opening Ceremony | - | - |
| 2026-09-17 | 09:00~09:10 | From user experience to scholarly impact: Modernizing Journal of Gastric Cancer | Han Hong Lee(The Catholic University of Korea) | - |
| 2026-09-17 | 09:10~09:25 | Discordance in Claudin 18.2 expression between primary and metastatic lesions in patients with gastric cancer | Hye Sook Han(Chungbuk National University) | - |
| 2026-09-17 | 09:25~09:40 | The influence of lifestyle behaviors and body mass index changes on long-term outcomes after gastric cancer surgery: A population-based cohort study | Ju-Hee Lee(Hanyang University) | - |
| 2026-09-17 | 09:40~09:55 | Endoscopic features of background gastritis associated with remnant gastric cancer: A multicenter retrospective study | Takuma Ohashi(Japanese Red Cross Kyoto First Hospital) | - |
| 2026-09-17 | 09:55~10:10 | Long-term survival following endoscopic submucosal dissection versus gastrectomy in early gastric cancer patients aged 75 years and above: A national retrospective cohort study in Korea | Sangwon Lee(National Cancer Center) | - |
| 2026-09-17 | 10:20~10:40 | Break | - | - |
| 2026-09-17 | 10:40~10:50 | (구연)Interim analysis of the UMC-UPPERGI-01 Randomized Clinical Trial: Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer | Quang Thong DANG(University Medical Center at Ho Chi Minh City Vietnam) | - |
| 2026-09-17 | 10:50~11:00 | (구연)Perioperative Tislelizumab(T) Combined with Apatinib(A) and SOX vs SOX for Borrmann Type IV, Large Borrmann Type III and Bulky N+ Advanced Gastric/gastroesophageal Junction(G/GEJ) Adenocarcinoma (AGC): a randomized phase III trial | Yi WANG(Fujian Cancer Hospital China) | - |
| 2026-09-17 | 11:00~11:10 | (구연)Interferon and tertiary-lymphoid-structure axes and a stromal immune barrier in gastric cancer: a multi-platform spatial atlas | Yoon Young CHOI(Soonchunhyang University Bucheon Hospital) | - |
| 2026-09-17 | 11:10~11:30 | Successful cancer control in Korea | Han-Kwang Yang(National Cancer Center) | - |
| 2026-09-17 | 11:30~12:00 | Rethinking treatment intent: Biomarkers and the evolving limits of cure in gastric cancer | Hanneke W.M. van Laarhoven(Amsterdam University Medical Center Netherlands) | - |
| 2026-09-17 | 12:00~13:00 | Beyond resection: Optimizing gastric surgery from transection to hemostasis | Myoung-Won Son(Soonchunhyang University) | - |
| 2026-09-17 | 13:00~13:20 | AI-driven surgical quality assessment in gastric cancer surgery | Takahiro Kinoshita(National Cancer Center Hospital East Japan) | - |
| 2026-09-17 | 13:20~13:40 | Surgical intelligence: When video becomes data in gastric cancer surgery | Chang In Choi(Pusan National University) | - |
| 2026-09-17 | 13:40~14:00 | Surgeon qualification system in multicenter RCTs and clinical practice in China | Ziyu Li(Peking University Cancer Hospital and Institute) | - |
| 2026-09-17 | 14:00~14:20 | The endoscopic surgical skill qualification system for stomach in Japan | Susumu Shibasaki(Fujita Health University Japan) | - |
| 2026-09-17 | 14:20~14:40 | Break | - | - |
| 2026-09-17 | 14:40~15:00 | Changes in gastric mucosa after Helicobacter Pylori eradication | Jong Yeul Lee(National Cancer Center) | - |
| 2026-09-17 | 15:00~15:20 | Characteristics of gastric cancer after eradication | Jae Myung Park(The Catholic University of Korea) | - |
| 2026-09-17 | 15:20~15:40 | Optimal surveillance after endoscopic resection of gastric cancer | Jae Yong Park(Chung-Ang University) | - |
| 2026-09-17 | 15:40~16:00 | Restoration of immune function after eradication and gastric cancer | Jie-Hyun Kim(Yonsei University) | - |
| 2026-09-17 | 16:00~16:20 | Break | - | - |
| 2026-09-17 | 16:20~16:40 | Clinical significance of histological types in ESD specimens | Myeong-Cherl Kook(National Cancer Center) | - |
| 2026-09-17 | 16:40~17:00 | Classic stain, modern insights: H&E morphology predicts patient outcomes | Heike I. Grabsch(Maastricht University Medical Center Netherlands) | - |
| 2026-09-17 | 17:00~17:20 | The evolution of PD-L1 evaluation in gastric cancer | Youngsoo Park(University of Ulsan) | - |
| 2026-09-17 | 17:20~17:40 | AI-driven pathology and spatial transcriptomics in gastric cancer | Sung Hak Lee(The Catholic University of Korea) | - |
| 2026-09-17 | 09:00~09:20 | The significance of intraperitoneal paclitaxel chemotherapy in the era of immunotherapy | Won Jun Seo(Korea University) | - |
| 2026-09-17 | 09:20~09:40 | Intraperitoneal chemotherapy for gastric cancer: Current role in peritoneal metastasis and future potential as adjuvant therapy | Hironori Ishigami(The University of Tokyo Hospital Japan) | - |
| 2026-09-17 | 09:40~10:00 | Next-generation intraperitoneal oncolytic viral immunotherapy for gastric cancer peritoneal metastases: Clinical translation of the CF33 platform | Yanghee Woo(City of Hope National Medical Center USA) | - |
| 2026-09-17 | 10:00~10:20 | Differential TME between primary and metastasis in gastric cancer | Yoonjin Kwak(Seoul National University) | - |
| 2026-09-17 | 10:20~10:40 | Break | - | - |
| 2026-09-17 | 10:40~10:50 | (구연)Interim analysis of the UMC-UPPERGI-01 Randomized Clinical Trial: Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer | Quang Thong DANG(University Medical Center at Ho Chi Minh City Vietnam) | - |
| 2026-09-17 | 10:50~11:00 | (구연)Perioperative Tislelizumab(T) Combined with Apatinib(A) and SOX vs SOX for Borrmann Type IV, Large Borrmann Type III and Bulky N+ Advanced Gastric/gastroesophageal Junction(G/GEJ) Adenocarcinoma (AGC): a randomized phase III trial | Yi WANG(Fujian Cancer Hospital China) | - |
| 2026-09-17 | 11:00~11:10 | (구연)Interferon and tertiary-lymphoid-structure axes and a stromal immune barrier in gastric cancer: a multi-platform spatial atlas | Yoon Young CHOI(Soonchunhyang University Bucheon Hospital) | - |
| 2026-09-17 | 11:10~11:30 | Successful cancer control in Korea | Han-Kwang Yang(National Cancer Center) | - |
| 2026-09-17 | 11:30~12:00 | Rethinking treatment intent: Biomarkers and the evolving limits of cure in gastric cancer | Hanneke W.M. van Laarhoven(Amsterdam University Medical Center Netherlands) | - |
| 2026-09-17 | 12:00~13:00 | Pembrolizumab in gastric cancer: Evolving treatment paradigms following reimbursement expansion and the introduction of the subcutaneous formulation | Dong-Hoe Koo(Sungkyunkwan University) | - |
| 2026-09-17 | 13:00~13:20 | Closing the gap: Endoscopic techniques for mucosal defect management in the upper GI tract | Mayo Tanabe(Showa University Japan) | - |
| 2026-09-17 | 13:20~13:40 | Application of robotic technology in endoscopic resection | Hyuk Soon Choi(Korea University) | - |
| 2026-09-17 | 13:40~14:00 | Endoscopic vacuum therapy for treatment of leaks or fistulas | Tae-Se Kim(Sungkyunkwan University) | - |
| 2026-09-17 | 14:00~14:20 | Unconventional ESD beyond submucosa: WPM/EIM | Katsuro Ichimasa(Showa University Japan) | - |
| 2026-09-17 | 14:20~14:40 | Break | - | - |
| 2026-09-17 | 14:40~15:00 | AI-based anatomical recognition in robotic gastrectomy | Kazutaka Obama(Kyoto University Japan) | - |
| 2026-09-17 | 15:00~15:20 | Reinforcing anastomotic safety: AI-enabled assessment | Hoseok Seo(The Catholic University of Korea) | - |
| 2026-09-17 | 15:20~15:40 | AI-based surgical phase recognition in gastric cancer surgery | Seong-Ho Kong(Seoul National University) | - |
| 2026-09-17 | 15:40~16:00 | Translating CVS-inspired AI methodologies to gastric cancer surgery | Pietro Mascagni(IHU-Strasbourg France) | - |
| 2026-09-17 | 16:00~16:20 | Break | - | - |
| 2026-09-17 | 16:20~16:40 | Intraop bleeding control and hemostasis checkpoints to minimizing postoperative bleeding | Hyung-Ho Kim(Chung-Ang University) | - |
| 2026-09-17 | 16:40~17:00 | CAVING approach using laparoscopy and robot-assisted surgery for para-aortic lymph node dissection | Keiji Hayata(Wakayama Medical University Japan) | - |
| 2026-09-17 | 17:00~17:20 | How I perform safe supra-pancreatic lymphadenectomy: Preventing pancreatic fistula in gastrectomy | Ichiro Uyama(Fujita Health University Japan) | - |
| 2026-09-17 | 17:20~17:40 | Dos and don’ts in robotic gastrectomy | Woo Jin Hyung(Yonsei University) | - |
| 2026-09-17 | 09:00~09:20 | Role of AI in endoscopy quality assurance | Jun-Won Chung(Gachon University) | - |
| 2026-09-17 | 09:20~09:40 | AI assisted detection and characterization of early gastric cancer | Chang-Seok Bang(Hallym University) | - |
| 2026-09-17 | 09:40~10:00 | AI based pathologic prediction of gastric cancer | Soo-Jeong Cho(Seoul National University) | - |
| 2026-09-17 | 10:00~10:20 | Real-time AI-assisted diagnosis of early gastric cancer | Kazutoshi Higuchi(Nippon Medical School Japan) | - |
| 2026-09-17 | 10:20~10:40 | Break | - | - |
| 2026-09-17 | 10:40~10:50 | (구연)Interim analysis of the UMC-UPPERGI-01 Randomized Clinical Trial: Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer | Quang Thong DANG(University Medical Center at Ho Chi Minh City Vietnam) | - |
| 2026-09-17 | 10:50~11:00 | (구연)Perioperative Tislelizumab(T) Combined with Apatinib(A) and SOX vs SOX for Borrmann Type IV, Large Borrmann Type III and Bulky N+ Advanced Gastric/gastroesophageal Junction(G/GEJ) Adenocarcinoma (AGC): a randomized phase III trial | Yi WANG(Fujian Cancer Hospital China) | - |
| 2026-09-17 | 11:00~11:10 | (구연)Interferon and tertiary-lymphoid-structure axes and a stromal immune barrier in gastric cancer: a multi-platform spatial atlas | Yoon Young CHOI(Soonchunhyang University Bucheon Hospital) | - |
| 2026-09-17 | 11:10~11:30 | Successful cancer control in Korea | Han-Kwang Yang(National Cancer Center) | - |
| 2026-09-17 | 12:00~13:00 | TEVIMBRA in Upper GI Cancers : Clinical Data and Real-World Insights | Minsu Kang(Seoul National University) | - |
| 2026-09-17 | 13:00~13:20 | Global lifetime burden of H.pylori-associated gastric cancer | Jin Young Park(IARC (International Agency for Research on Cancer) France) | - |
| 2026-09-17 | 11:30~12:00 | Rethinking treatment intent: Biomarkers and the evolving limits of cure in gastric cancer | Hanneke W.M. van Laarhoven(Amsterdam University Medical Center Netherlands) | - |
| 2026-09-17 | 13:20~13:40 | AI-based gastric cancer screening from non-contrast CT image | Xiangdong Cheng(Zhejiang Cancer Hospital China) | - |
| 2026-09-17 | 13:40~14:00 | Influence of procedural volume on the outcome of ESD: A nationwide population-based study | Jae Gyu Kim(Chung-Ang University) | - |
| 2026-09-17 | 14:00~14:20 | Improving gastric cancer surgery quality from K-QIPS data | Sang-Uk Han(Ajou University) | - |
| 2026-09-17 | 14:20~14:40 | Break | - | - |
| 2026-09-17 | 14:40~15:00 | Optimal patient selection for neoadjuvant chemo-immunotherapy and surgical approach | Takaki Yoshikawa(National Cancer Center Japan) | - |
| 2026-09-17 | 15:00~15:20 | Radiologic evaluation for neoadjuvant chemotherapy response | Suk Hee Heo(Chonnam National University) | - |
| 2026-09-17 | 15:20~15:40 | Biomarker-Driven tailored perioperative strategies in gastric cancer | Keun-Wook Lee(Seoul National University) | - |
| 2026-09-17 | 15:40~16:00 | Role of neoadjuvant immunotherapy in resectable gastric cancer | Sun Young Rha(Yonsei University) | - |
| 2026-09-17 | 16:00~16:20 | Break | - | - |
| 2026-09-17 | 16:20~16:40 | Predicting metachronous recurrence via gastric microbiome | Nayoung Kim(Seoul National University) | - |
| 2026-09-17 | 16:40~17:00 | Fecal microbiome as a marker of gastric precancerous lesions and gastric cancer | Hyo Joon Yang(Sungkyunkwan University) | - |
| 2026-09-17 | 17:00~17:20 | Impact of the intratumoral resident microbiome on the tumor microenvironment of gastric cancer | Hoon Hur(Ajou University) | - |
| 2026-09-17 | 17:20~17:40 | Influence of the gut microbiota on cancer immunotherapy response | Hansoo Park(GIST) | - |
| 2026-09-17 | 09:00~09:20 | 1st solid tumor CAR-T in treatment of gastrointestinal cancer | Changsong Qi( Beijing Cancer Hospital, China) | - |
| 2026-09-17 | 09:20~09:27 | (구연)Changes in treatment pattern and long-term survival of patients with gastric cancer: the impact of National Cancer Screening Program | Woojun AHN(National Cancer Center) | - |
| 2026-09-17 | 09:27~09:34 | (구연)Integrative Single-Cell and Spatial Transcriptomic Atlas Reveals Immunosuppressive Microenvironment and Metastatic Niche of Hepatoid Adenocarcinoma of the Stomach | Jiatian TANG(Peking University Cancer Hospital & Institute China) | - |
| 2026-09-17 | 09:34~09:41 | (구연)Future and Lifetime Preventable Burden of Gastric Cancer Incidence Attributable to Modifiable Risk Factors in China: A Population-Based Study | JUNYAO YE(Guangdong Medical University China) | - |
| 2026-09-17 | 09:41~09:48 | (구연)Spatial single-cell multi-omics profiling of HER-2-defined tumor microenvironment heterogeneity in gastric cancer | Haoxin PENG(Peking University Cancer Hospital and Institute China) | - |
| 2026-09-17 | 09:48~09:55 | (구연)No disparity in gastric cancer-specific mortality between capital and non-capital area treatment: A nationwide cohort study using the K-CURE database, 2012-2020 | Woojun AHN(National Cancer Center) | - |
| 2026-09-17 | 09:55~10:02 | (구연)Single-Cell Atlas Reveals Neuroendocrine-Lineage Dominance and Actionable Therapeutic Vulnerabilities in Gastric Mixed Adenoneuroendocrine Carcinoma | Jiatian TANG(Peking University Cancer Hospital & Institute) | - |
| 2026-09-17 | 10:02~10:09 | (구연)Impact of Medical Workforce Disruption on Gastric Cancer Treatment Patterns in Korea: A Nationwide HIRA Claims-Based Analysis | Kyo Young SONG(The Catholic University of Korea) | - |
| 2026-09-17 | 10:09~10:16 | (구연)Single-Cell Dissection of Lymph Node Immune Remodeling in Gastric Cancer: From Activation to Dysfunction Along the Tumor-Draining Lymphatic Axis | Peiyu Zhu(Peking University Cancer Hospital & Institute) | - |
| 2026-09-17 | 10:20~10:40 | Break | - | - |
| 2026-09-17 | 13:00~13:20 | Long-term survival with first-line nivolumab in advanced gastric cancer: Insights from CheckMate-649 and Korean experience | Jeesun Yoon(Seoul National University) | - |
| 2026-09-17 | 13:20~13:27 | (구연)Effect of long-limb Roux-en-Y reconstruction on early glycemic control compared with Billroth II after subtotal gastrectomy in patients with type 2 diabetes and gastric cancer: 6-Month interim analysis | Inyoung LEE(Korea University College of Medicine) | - |
| 2026-09-17 | 13:27~13:34 | (구연)Early Postoperative Exercise Enhances Recovery after Gastrectomy: A Randomized Clinical Trial | Taeho LEE(Yonsei University) | - |
| 2026-09-17 | 13:34~13:41 | (구연)Long-Term Oncological Outcomes of Robotic versus Laparoscopic Gastrectomy for Gastric Cancer: A Multi-institutional Propensity Score-Matched Study | Tatsuto NISHIGORI(Kyoto City Hospital Japan) | - |
| 2026-09-17 | 13:41~13:48 | (구연)Continuous Transversus Abdominis Plane Block after Minimally Invasive Gastrectomy for Gastric Cancer: a Randomized Controlled Trial | Soon Jae KWON(Seoul National University Bundang Hospital) | - |
| 2026-09-17 | 13:48~13:55 | (구연)Reappraisal of Miettinen criteria in adjuvant imatinib era | GUNHO KIM(Hanyang University College of Medicine) | - |
| 2026-09-17 | 13:55~14:02 | (구연)National Delphi Consensus Study on Harmonization of PD-L1 IHC Assays for First-line Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Gastric Cancer in Korea: A Study Protocol | Won Jun SEO(Korea University College of medicine) | - |
| 2026-09-17 | 14:02~14:09 | (구연)Prognostic Heterogeneity among Subgroups within Modified NIH Risk Classification in Gastric Gastrointestinal Stromal Tumors: A Single-center Cohort Analysis | SAHONG KIM(Inha University Hospital) | - |
| 2026-09-17 | 14:09~14:16 | (구연)Three-Year Outcomes of Perioperative Camrelizumab Plus Apatinib Combined with Chemotherapy Versus Apatinib Plus Chemotherapy and Chemotherapy Alone in Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial | Ping LI(Fujian Medical University Union Hospital) | - |
| 2026-09-17 | 14:20~14:40 | Break | - | - |
| 2026-09-17 | 14:40~15:00 | Clinical experience with Clean-NET: Techniques and case-based discussion | Dong Jin Kim(The Catholic University of Korea) | - |
| 2026-09-17 | 15:00~15:07 | (구연)Therapeutic Value Index–Based Reappraisal of Lymphadenectomy in Upper-Third Gastric Cancer: Implications for D2 Dissection and Proximal Gastrectomy | Chungyoon KIM(Seoul National University Hospital) | - |
| 2026-09-17 | 15:07~15:14 | (구연)Clinical significance of posterior pancreaticoduodenal lymph node (No. 13) dissection for gastric cancer with duodenal invasion | SHOICHI NAKAMURA(Kitakyushu Municipal Medical Center Japan) | - |
| 2026-09-17 | 15:14~15:21 | (구연)Comparison of SP Reduced-Port and Conventional Multiport Robotic Gastrectomy for Gastric Cancer: A Propensity-Matched Analysis | Ki-Yoon KIM(Kangbuk Samsung Hospital) | - |
| 2026-09-17 | 15:21~15:28 | (구연)Automated Assessment of Surgical Quality in Distal Gastrectomy: Development of a Novel Computer Vision Model Based on the Critical View of Quality (CVQ) | Jeesun Sunny KIM(Ewha Womans University Mokdong Hospital) | - |
| 2026-09-17 | 15:28~15:35 | (구연)Comparative Short-Term Outcomes of Robotic Distal Gastrectomy for Gastric Cancer Using the hinotori™ and da Vinci Surgical Systems | MASAAKI NISHI(Tokushima University Japan) | - |
| 2026-09-17 | 15:35~15:42 | (구연)Surgical Technique and Outcomes of Robot-Assisted Gastrectomy Using the Hugo™ RAS System | Shintaro OKUMURA(Kyoto University Hospital Japan) | - |
| 2026-09-17 | 15:42~15:49 | (구연)Soft coagulation scissors versus an ultrasonically activated device during robotic distal gastrectomy for advanced gastric cancer: a single-institution cohort study focused on postoperative inflammation | Tomoki KONISHI(Japanese Red Cross Kyoto Daini Hospital Japan) | - |
| 2026-09-17 | 15:49~15:56 | (구연)Robotic Gastrectomy for Gastric Cancer: A Comparative Analysis Between Eastern and Western Specialized Centers | Ludovico CARBONE(Seoul National University Hospital) | - |
| 2026-09-17 | 16:00~16:20 | Break | - | - |
| 2026-09-17 | 16:20~16:40 | Impact of Antipyretic and Analgesic Strategies on Postoperative Recovery After Minimally Invasive Gastrectomy | Sung Hyun Park(Yonsei University) | - |
| 2026-09-17 | 16:40~16:47 | (구연)Diagnostic Performance of Preoperative Indocyanine Green Fluorescent Lymphography during Additional Gastrectomy after Non-Curative Endoscopic Submucosal Dissection | Gennaro MELONE(University of Rome Campus Biomedico Italy) | - |
| 2026-09-17 | 16:47~16:54 | (구연)Single-Incision Laparoscopic Gastrectomy (SILG) for Gastric Cancer Achieves Comparable Long-Term Survival with Improved Operative Outcomes: An Inverse Probability of Treatment Weighting Analysis of 1,526 SILG Patients | So Hyun KANG(Seoul National University Bundang Hospital) | - |
| 2026-09-17 | 16:54~17:01 | (구연)Surgical Quality after Neoadjuvant Chemotherapy for Gastric Cancer: A Nationwide Propensity Score-Matched Textbook Outcome Analysis | SEUL GI OH(Asan Medical Center) | - |
| 2026-09-17 | 17:01~17:08 | (구연)Improved Short-Term Outcomes of Robotic Radical Gastrectomy Using the RUS™ Surgical Navigation System in Obese Patients with Gastric Cancer: A Propensity Score-Matched Study | Jawon HWANG(Yonsei Cancer Center) | - |
| 2026-09-17 | 17:08~17:15 | (구연)Comparison of Postoperative Quality of Life After Function-Preserving Gastrectomy: A Secondary Analysis of Prospective Multicenter Trials (KLASS-04 vs. KLASS-05 vs. SENORITA) | Sang Soo EOM(Ilsan Paik Hospital) | - |
| 2026-09-17 | 17:15~17:22 | (구연)Long-Term Conditional Survival After Proximal Gastrectomy Versus Total Gastrectomy for Proximal Gastric Cancer: A Propensity Score–Matched Landmark Analysis | So Hyun KANG(Seoul National University Bundang Hospital) | - |
| 2026-09-17 | 17:22~17:29 | (구연)Individualized Efficacy Analysis of the Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer | Xicheng WEI(Beijing Friendship Hospital China) | - |
| 2026-09-17 | 17:29~17:36 | (구연)Predictors of the Natural Course of Dumping Syndrome After Gastric Cancer Surgery; a collateral study of KLASS-04 | Whei Kyong JUNG(Seoul National University Hospital) | - |
비고
[사전등록] KGCA회원(IGCA회원):20만원/KGCA회원(IGCA비회원):30만원/KGCA공동심포지엄참여학회회원:30만원/KGCA비회원:40만원/연구원,간호사,군의관,공중보건의:5만원/전공의,원로회원,학생,초청연자및좌장:무료[현장등록] KGCA회원(IGCA회원):30만원/KGCA회원(IGCA비회원):40만원/KGCA공동심포지엄참여학회회원:40만원/KGCA비회원:50만원/연구원,간호사,군의관,공중보건의:10만원/전공의,원로회원,학생 무료
문의처
담당자
김지혜
연락처
02-730-3760
이메일
kgca@kgca-i.or.kr